Skip to content

Dr. Rosseels Alexander

Active
Private limited companyfounded 2017active for 9 yearsKoningin Elisabethlaan 13, 3920 Lommel, BelgiumKBO/BCE: BE 0681.511.508
Summary

Dr. Rosseels Alexander has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €72,890 and a net result of €49,735. Equity has been growing by about 14% per year since 2018. Its solvency ranks better than 47% of 617 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-09-2017 Normal situation
Activity
Other research and development on natural sciences NACE 72109and 2 others
Establishment unit
2.267.851.684 3970 Leopoldsburg, since 19-09-2017
Financial year end
31 December
Peppol
Reachable since 01-09-2025

Board and ownership

Board
  • Rosseels AlexanderDirector

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€83,411
▼ 0.3%
Turnover
≈ €250,000
estimated
Profit
€49,735
▼ 15.8%
Equity
€72,890
▼ 32.6%
Total assets
€127,562
▲ 10.7%
Score breakdownlowers riskLiquidity: current ratio 1.92, cash €66,860Sector: Scientific research and development (NACE 72)Equity €72,890 (57.1% of total assets)Size: total assets €127,562Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 57% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 82-18
equity 57.1% of total assets
Liquidity 80-20
short-term debt 42.3% · cash 52.4%
Profitability 100=
return on assets 39.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.2 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.92 (13.57 in 2024), above the usual 1.5. Short-term debt is 42.3% and cash 52.4% of total assets. 42.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 50% of them on solvency, 67% on liquidity, 90% on profitability and 21% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 1.92, cash €66,860
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
lowers risk · Equity €72,890 (57.1% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €127,562
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
17 days early
2024
13 days early
2023
13 days early
2022
4 days early
2021
3 days early
2020
9 days early
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 9 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €49,735 8 years View

Recent changes

  1. · Gazette deed Purpose · Amendment of the articles · Legal-form change · Resignations & appointments · Miscellaneous
  2. · Gazette deed Registered office moved within Lommel
  3. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as Dr. Rosseels Alexander: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €88,500 and €189,000, founded between 2017 and 2019.

CompanyTotal assetsGross margin
Dr. Rosseels Alexander Lommel€127,562€83,411
CUBATIK Crisnée€151,712€88,630
Vascular Research Center Bonheiden Herenthout€159,871€111,925
MDSMEERS Mortsel€130,965€118,915
RAPHUS Rixensart€132,495€132,093
Dokter Katrien Scheers huisarts Keerbergen€88,527€71,695
JTA CONSULTING Anderlecht€189,416€103,045
Full comparison

Key facts about Dr. Rosseels Alexander

What is the company number of Dr. Rosseels Alexander?
The company number of Dr. Rosseels Alexander is 0681.511.508. The VAT number is the same number with BE in front: BE 0681.511.508.
Where is Dr. Rosseels Alexander based?
The registered office is at Koningin Elisabethlaan 13, 3920 Lommel.Company details
What does Dr. Rosseels Alexander do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of Dr. Rosseels Alexander?
The legal form of Dr. Rosseels Alexander is Private limited company (BV).
When was Dr. Rosseels Alexander founded?
Dr. Rosseels Alexander was founded on 19-09-2017.
Is Dr. Rosseels Alexander still active?
Yes, Dr. Rosseels Alexander is an active enterprise in the KBO register.
What is the turnover of Dr. Rosseels Alexander?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €83,411 and 2,672 comparable companies of the same size. It probably lies between €170,000 and €430,000. It is a rough estimate.Financials
Is Dr. Rosseels Alexander profitable?
In financial year 2025, Dr. Rosseels Alexander made a profit of €49,735.
Where can I find the annual accounts of Dr. Rosseels Alexander?
Dr. Rosseels Alexander filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Rosseels Alexander due?
Dr. Rosseels Alexander must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.